Lewes, DE -- (SBWIRE) -- 09/24/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Liberty Interactive (Interactive group) (NASDAQ:LINTA), Mylan Inc (NASDAQ:MYL), Myriad Genetics, Inc. (NASDAQ:MYGN), MannKind Corporation (NASDAQ:MNKD).
Liberty Interactive (Interactive group) (NASDAQ:LINTA) opened its last trade at the price of $24.64. Its closing price was $24.05 after losing -1.96% for the day. The company traded with the total volume of 3.35 million shares, while its average trading volume remained 2.08 million shares. The beta of this stock stands at 2.24.
Liberty Interactive Corporation, through its subsidiaries, engages in video and on-line commerce businesses in North America, Europe, and Asia.
Will LINTA Get Buyers Even After The Recent Rally? Find Out Here
Mylan Inc (NASDAQ:MYL) percentage change plunged -1.53% to close at $38.07 with the total traded volume of 3.34 million shares. That activity was less than average volume of 4.43 million. The 52 week range of the stock remained $23.25 - $39.41, while its day lowest price was $37.83. The share price hit the day highest price of $38.54.
Mylan Inc. engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs) worldwide. It operates in two segments, Generics and Specialty.
Will MYL Get Buyers Even After The Recent Rally? Find Out Here
Myriad Genetics, Inc. (NASDAQ:MYGN) traded on volume of 3.32 million shares in the last session against average volume of 1.92 million shares. The company started its trading session with the price of $25.09 and closed at $24.40 by scoring -2.77%.In the last three months the stock was down -5.24% while its 52 week range of the stock was $24.08 - $38.27.
Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States.
Will MYGN Get Buyers Even After The Recent Rally? Find Out Here
MannKind Corporation (NASDAQ:MNKD) started its last trading session with the price of $5.90 and closed at $5.91 by scoring -0.35%. The stock traded with total volume of 3.29 million shares, while the average trading volume remained 9.34 million shares. The beta value of this stock stands at 1.47. Day range for the stock was $5.88 and $5.98.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Will MNKD Get Buyers Even After The Recent Rally? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/